PALISADE CAPITAL MANAGEMENT, LP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 99 filers reported holding INTERSECT ENT INC in Q2 2016. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q3 2016$716,000
-9.9%
45,200
-26.5%
0.02%
-13.8%
Q2 2016$795,000
-82.2%
61,500
-73.8%
0.03%
-80.1%
Q1 2016$4,466,000
+4.5%
235,073
+23.8%
0.15%
+5.0%
Q4 2015$4,272,000
+5.8%
189,846
+10.0%
0.14%
+16.8%
Q3 2015$4,039,000172,6190.12%
Other shareholders
INTERSECT ENT INC shareholders Q2 2016
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 238,698$3,781,0003.74%
PURA VIDA INVESTMENTS, LLC 275,000$4,356,0001.32%
Broadfin Capital, LLC 638,600$10,115,0000.91%
Aisling Capital LLC 248,498$3,936,0000.81%
Bellevue Group AG 205,325$3,252,0000.59%
Iguana Healthcare Management, LLC 180,000$2,852,0000.51%
Rock Springs Capital Management LP 345,000$5,465,0000.34%
SECTORAL ASSET MANAGEMENT INC 168,140$2,663,0000.26%
FORMULA GROWTH LTD 62,213$985,0000.22%
MENTA CAPITAL LLC 111,915$1,773,0000.17%
View complete list of INTERSECT ENT INC shareholders